ReviewArchives of microbiology2025
Microbial membrane vesicles and the intestinal epithelium: a crosstalk in health and disease.
Review in Archives of microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Bacterial Outer Membrane Vesicles: Research Advances from Biogenesis Mechanisms to Engineered Applications.Membranes · 2026Review
- Gut microbiota-immune crosstalk in osteoarthritis: pathogenic mechanisms and emerging therapeutic opportunities.Frontiers in microbiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The intestinal epithelium maintains a critical dialogue with the gut microbiota. A key mechanism in this communication is the release of bacterial membrane vesicles (MVs), which act as functional carriers of bioactive cargo. This review explores the central role of MVs in mediating the crosstalk between the gut microbiota and the intestinal epithelium. We summarize the biogenesis of Gram-negative outer membrane vesicles (OMVs) and Gram-positive cytoplasmic membrane vesicles (CMVs) and detail the molecular pathways of their interaction with host intestinal epithelial cells, including endocytic uptake and pattern recognition receptor signaling. We then discuss the dual role of this communication: MVs from commensal bacteria are crucial for maintaining intestinal homeostasis by enhancing barrier integrity and modulating immune responses, while MVs from pathogenic bacteria contribute to diseases like inflammatory bowel disease (IBD) and colorectal cancer (CRC) by delivering virulence factors and promoting inflammation. Finally, we critically evaluate the emerging potential of MVs as non-invasive diagnostic biomarkers and as engineered therapeutic platforms for targeted drug delivery and vaccination, while highlighting the significant translational challenges that remain.
Indexed as
Identifiers
41191120What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.